Results

Total Results: 1,540 records

Showing results for "month".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
    June 01, 2025 - White Paper: Living Systematic Reviews: Practical Considerations for Adapting Scope and Communicating the Evolving Evidence White Paper Living Systematic Reviews: Practical Considerations for Adapting Scope and Communicating the Evolving Evidence White Paper Living Systematic Reviews: Practical Conside…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_disposition-comments.pdf
    February 13, 2012 - Comparative Effectiveness Research Review Disposition of Comments Report http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=960 Published Online: February 13, 2012 Comparative Effectiveness Research Review Disposition of Comments Report Research…
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_executive.pdf
    August 01, 2013 - N = 468) Unknown Precise for reduction in arrests for crimes other than parole violations at 6 month
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
    May 29, 2025 - 2011 Yes Yes No Yes No No Yes Yes Yes Yes Yes Yes Yes Medium-low Wait list randomized after 3 month
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
    November 01, 2016 - have shown that improvements in pain (mean reduction to 58% of initial pain scores) occurred in 1 month
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  7. effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - we initially graded the evidence as moderate given the consistency of the results and long-term (6-month … We initially graded the evidence as moderate given the consistency of the results and long- term (6-month … we initially graded the evidence as moderate given the consistency of the results and long-term (6-month
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - we initially graded the evidence as moderate given the consistency of the results and long-term (6-month … We initially graded the evidence as moderate given the consistency of the results and long- term (6-month … we initially graded the evidence as moderate given the consistency of the results and long-term (6-month
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Age 1 month to 18 years old is a wide age range; a correspondingly wide range of developmental changes … P26, Limes 42 – 51: This paragraph uses two different metrics-risk difference in episodes par month … and -10.5 dB respectively, with 95% credible intervals that exclude a null effect in the 1 to 3 month
  10. effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Age 1 month to 18 years old is a wide age range; a correspondingly wide range of developmental changes … P26, Limes 42 – 51: This paragraph uses two different metrics-risk difference in episodes par month … and -10.5 dB respectively, with 95% credible intervals that exclude a null effect in the 1 to 3 month
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-noninvasive-nonpharma.pdf
    April 01, 2022 - That report included randomized controlled trials (RCTs) reporting outcomes at least 1 month following … full-text review was inadequate duration of followup postintervention in nine trials (i.e., followup <1-month … Chronic headache is defined as 15 or more days each month for at least 12 weeks or history of headache … months), intermediate term (≥6 to <12 months) and long term (≥12 months); focus on longer term (>12 month … • Studies with <1 month followup after treatment B-5 PICOTS Inclusion Exclusion Studies
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-nerve-block-protocol.pdf
    November 18, 2023 - Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery Evidence-based Practice Center Systematic Review Protocol Project Title: Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery I. Background and Objectives for the Systematic Review Millio…
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
    August 10, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: August 10, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-risk Preschoolers; Long…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
    June 24, 2014 - CER 5 Renal Artery Stenosis NSD SJ Clean Renal Artery Stenosis Nomination Summary Document Results of Topic Selection Process & Next Steps § The topic, Renal Artery Stenosis,…
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
    April 01, 2011 - EE maintenance - A 6-month, multicenter, double-blind, randomized, placebo-controlled trial evaluated … Two-thirds, or 66%, of patients treated with dexlansoprazole 30 mg remained healed over the 6- month … Histology – The long-term histological safety of dose-titrated lansoprazole was evaluated in an 82-month … trial program (6 randomized, double-blind, controlled studies and one randomized, open-label, 12-month
  16. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain-surveillance-151130.pdf
    July 10, 2015 - Painful symptoms and perception of stress were recorded 1 month after surgery. … MEASURE(S): Perceived stress scale (PSS) and visual analog scale for painful symptoms before and 1 month … The intensity of chronic pelvic pain and dyspareunia significantly decreased at 6-month treatment in … At 6-month treatment, the number of migraine attacks was lower than at baseline in group POP (p=0.002 … The intensity of migraine attacks was significantly different between baseline and 6-month treatment
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-urinary-retention_disposition-comments.pdf
    September 15, 2014 - Disposition of Comments for Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments Draft review available for public…
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
    March 14, 2012 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: March 14, 2012 Evidence-based Practice Center Systematic Review Protocol Project Title: Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Cons…
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
    October 01, 2018 - agreement was reached on the basic content, we refined the content and slides over an approximately 1-month … including the evaluation process) involved about four conference calls and email communication over a 2-month
  20. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - prescription-drug prices, GoodRx, liraglutide under the name Saxenda costs up to about $1,200 per month … dosing, after the 5-week dose-escalation schedule, one carton of liraglutide represents about a 1- month … between $200 and $500 (lorcaserin, naltrexone/bupropion, orlistat, phentermine/topiramate) for a 1-month

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: